Hsu, Grace Chia-YenGrace Chia-YenHsuSHYANG-RONG SHIHChang, Fang-YuFang-YuChangSHU-LANG LIAOYI-HSUAN WEI2024-04-262024-04-262024-04-062193-8245https://scholars.lib.ntu.edu.tw/handle/123456789/642106Graves' ophthalmopathy (GO) is an autoimmune inflammatory disorder observed in a substantial proportion of patients with Graves' disease (GD), with debilitating symptoms of disfiguring, periorbital pain, dry eyes, diplopia, and even visual disturbances. Previous studies involving Western populations have noted discrepancies in risk factors for GO. Therefore, this study aimed to determine the risk factors for GO development and the protective effect of statins in newly diagnosed patients with GD in Taiwan.enGraves orbitopathy; Graves’ disease; Graves’ ophthalmopathy; Statins; Thyroid-associated ophthalmopathyjournal article10.1007/s40123-024-00930-1385816042-s2.0-85189356894https://api.elsevier.com/content/abstract/scopus_id/85189356894